Understanding the role of SAS1B in basic cancer biology, its splice variants and isoforms, and developing appropriate well characterized monoclonal antibodies for targeted therapy is of interest to us and is being actively pursued in our laboratory. The gene discussed is ASTL; the disease is cancer.